1992
DOI: 10.1016/s0021-9258(18)41732-2
|View full text |Cite
|
Sign up to set email alerts
|

Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
76
0
6

Year Published

1996
1996
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 741 publications
(91 citation statements)
references
References 28 publications
4
76
0
6
Order By: Relevance
“…We demonstrated previously that ENG binds TGF‐β1 and TGF‐β3 isoforms in association with TGFBR2 (46) and that Eng ‐/‐ ECs show reduced binding to TGF‐β1 as measured by affinity cross‐linking. ENG alters TGF‐β receptor levels in a very context‐dependent manner and determines the balance between ALK5 (Smad2 and Smad3 mediated) or ALK1 (Smad1, Smad5, and Smad8 mediated) pathways (47).…”
Section: Discussionmentioning
confidence: 81%
“…We demonstrated previously that ENG binds TGF‐β1 and TGF‐β3 isoforms in association with TGFBR2 (46) and that Eng ‐/‐ ECs show reduced binding to TGF‐β1 as measured by affinity cross‐linking. ENG alters TGF‐β receptor levels in a very context‐dependent manner and determines the balance between ALK5 (Smad2 and Smad3 mediated) or ALK1 (Smad1, Smad5, and Smad8 mediated) pathways (47).…”
Section: Discussionmentioning
confidence: 81%
“…These cells could be leukocytes, which have been shown to express PECAM-1 (Liao et al 1995). Nestin also co-localized with endoglin, which is a component of the transforming growth factor (TGF)-beta receptor complex (Cheifetz et al 1992). It has been shown that endoglin is expressed on endothelial cells of normal and especially proliferating blood vessels and is implicated in endothelial cell function (Gougos and Letarte 1990; Kumar et al 1996).…”
Section: Discussionmentioning
confidence: 99%
“…These cells varied in staining intensity and had often a stroma-like appearance. It has been reported that, in some tissues, endoglin and CD34 mark not only vascular endothelial cells but also fibroblasts and leukocytes, which could explain the additional occurrence of endoglin-positive/nestin-negative and CD34-positive/nestin-negative cells (Nakayama et al 2000; Balza et al 2001; O'Connell et al 1992). However, it can neither be excluded that a minute number of PECAM-1, CD34, and endoglin-positive endothelial cells of small blood vessels do not express nestin nor that nestin is expressed in a small subpopulation of non-endothelial cells that are also positive for the tested endothelial markers.…”
Section: Discussionmentioning
confidence: 99%
“…TGF-β receptor is an important key inducer of EMT-TFs, which changes expression levels of EMT markers in CRC [17,18]. CD105 (endoglin), as a neoangiogenesisrelated protein, is known as a component of TGF-β receptor and a regulator for TGF-β signaling [19]. Studies performed on cancer have reported that CD105 may induce EMT program through EMT-TFs and play a functional role in maintaining cancer stem cells (CSCs) [20,21].…”
Section: Introductionmentioning
confidence: 99%